Administration of ERα specific inhibitor MPP and ERβ specific inhibitor PHTPP showed that ERβ and not ERα is involved in the antihypertrophic effects against ISO induced cardiac hypertrophy. The gene discussed is ESR1; the disease is cardiac hypertrophy.